Across TCGA pan-cancer cohorts, RNU7-182P RNA is linked to patient survival in 2 of 34 cancer types, making it the most broadly survival-associated RNU7-182P data layer.
The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher RNU7-182P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU7-182P expression acts as an unfavorable survival marker.
OV and UCEC are the cancer types where RNU7-182P RNA most reproducibly stratifies survival.